645 related articles for article (PubMed ID: 36618350)
21. Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.
Adhikari S; Guha D; Mohan C; Mukherjee S; Tyler JK; Das C
Subcell Biochem; 2022; 100():3-65. PubMed ID: 36301490
[TBL] [Abstract][Full Text] [Related]
22. Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis.
Cheung AH; Hui CH; Wong KY; Liu X; Chen B; Kang W; To KF
Int J Cancer; 2023 Apr; 152(8):1510-1525. PubMed ID: 36093588
[TBL] [Abstract][Full Text] [Related]
23. Linking metabolic reprogramming to therapy resistance in cancer.
Morandi A; Indraccolo S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
[TBL] [Abstract][Full Text] [Related]
24. Metabolic dependencies and targets in ovarian cancer.
Zhang Y; Wang Y; Zhao G; Orsulic S; Matei D
Pharmacol Ther; 2023 May; 245():108413. PubMed ID: 37059310
[TBL] [Abstract][Full Text] [Related]
25. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer.
Wang G; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
Curr Cancer Drug Targets; 2019; 19(7):534-550. PubMed ID: 30360743
[TBL] [Abstract][Full Text] [Related]
26. Targeting glucose metabolism for cancer therapy.
Hamanaka RB; Chandel NS
J Exp Med; 2012 Feb; 209(2):211-5. PubMed ID: 22330683
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
[TBL] [Abstract][Full Text] [Related]
30. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
[TBL] [Abstract][Full Text] [Related]
31. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.
Sun NY; Yang MH
Front Oncol; 2020; 10():792. PubMed ID: 32509584
[TBL] [Abstract][Full Text] [Related]
32. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies.
Sheng H; Niu B; Sun H
Curr Med Chem; 2009; 16(13):1561-87. PubMed ID: 19442134
[TBL] [Abstract][Full Text] [Related]
33. The metabolic alterations of cancer cells.
Sciacovelli M; Gaude E; Hilvo M; Frezza C
Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
[TBL] [Abstract][Full Text] [Related]
34. Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids.
Mamouni K; Kallifatidis G; Lokeshwar BL
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671107
[TBL] [Abstract][Full Text] [Related]
35. [Metabolic reprogramming in cancer: the art of balance].
Yi M; Xiang B; Li X; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1177-87. PubMed ID: 24316928
[TBL] [Abstract][Full Text] [Related]
36. Metabolic deregulation in prostate cancer.
Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
[TBL] [Abstract][Full Text] [Related]
37. Metabolic implication of tumor:stroma crosstalk in breast cancer.
Morandi A; Chiarugi P
J Mol Med (Berl); 2014 Feb; 92(2):117-26. PubMed ID: 24458539
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.
Li Z; Zhang H
Cell Mol Life Sci; 2016 Jan; 73(2):377-92. PubMed ID: 26499846
[TBL] [Abstract][Full Text] [Related]
39. Metabolic crosstalk in the breast cancer microenvironment.
Dias AS; Almeida CR; Helguero LA; Duarte IF
Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
